FDA Releases Final Guidance for Cover Letter Attachments in Controlled Correspondence and ANDA Submissions

Summary

The Food and Drug Administration (FDA) has finalized a guidance document to assist industry with optional attachments for cover letters accompanying controlled correspondence, ANDA submissions, and other FDA filings.